Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis

H. C. Chang, A. Omar, S. Swift, A. C. Vandal, G. Liu, P. Kyme, C. Wong (Auckland, New Zealand; Los Angeles, United States Of America)

Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Session: Antibiotics, antifungals and other therapeutic options
Session type: Poster Discussion
Number: 4684
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. C. Chang, A. Omar, S. Swift, A. C. Vandal, G. Liu, P. Kyme, C. Wong (Auckland, New Zealand; Los Angeles, United States Of America). Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis. Eur Respir J 2014; 44: Suppl. 58, 4684

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical phenotypes in non-cystic fibrosis bronchiectasis (NCFBE)
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014

Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Exacerbations in non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Predictors of lung function decline in stable non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014

Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Is etiology of non-cystic fibrosis bronchiectasis (NCFBE) a risk factor for severe exacerbation?
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

Effect of long term azithromycin on exacerbations in non CF bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Aetiology of bronchiectasis: Evaluation of 319 adult patients with bronchiectasis
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


Cystic fibrosis: Achromobacter xylosoxidans colonized patients have more severe respiratory disease
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013

Predictors of exacerbations in patients with bronchiectasis
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Clinicopathological features of the pulmonary aspergillosis with chronic interstitial pneumonia
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014


Vitamin D levels in patients with non-CF bronchiectasis
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Anaerobic and aerobic bacterial load of childhood non- cystic fibrosis bronchiectasis
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014

Prolonged antibiotics for non-cystic fibrosis purulent bronchiectasis in children and adults: A Cochrane review
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


The weight of radiological severity in patients with non-CF bronchiectasis
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014

Prevalence of nontuberculosis mycobacterial in patients with bronchiectasis: A meta-analysis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014